ACADIA Pharmaceuticals

ACADIA Pharmaceuticals

Yahoo Finance • 14 hours ago

Capitalize on Breakthrough Therapy Designation Shifts: Benchmark Pfizer, Roche, Novartis, Merck and AstraZeneca to Accelerate Approvals, Defend Pipeline ROI and Capture Revenue

Company Logo Expedited FDA pathways are boosting oncology and rare-disease drug development, with gene therapy, immunotherapy and precision medicine creating key opportunities. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Breakthrough The... Full story

Yahoo Finance • 23 days ago

AcadeMedia (OM:ACAD) Reports Stronger Results, Is The 19% Upside Still There?

AcadeMedia (OM:ACAD) has drawn fresh attention after reporting its fourth quarter and full year results to June 30, 2026. The sales and net income figures indicate stronger operational performance across the education portfolio. The earni... Full story

Yahoo Finance • 30 days ago

Acadia Gets European Commission Nod for Daybu in Rett Syndrome

Acadia Pharmaceuticals ACAD announced that the European Commission (EC) has granted marketing authorization for Daybu (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and old... Full story

Yahoo Finance • 2 months ago

Acadia outlines $480M-$510M 2026 DAYBUE sales outlook as remlifanserin Phase II data nears Sep-Oct

Earnings Call Insights: ACADIA Pharmaceuticals (ACAD) Q2 2026 MANAGEMENT VIEW * CEO Catherine Owen Adams said ACADIA delivered total revenues of $308 million, driven by “strong commercial execution across both DAYBUE and NUPLAZID,” and... Full story

Yahoo Finance • 2 months ago

An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?

Key Points Principal Accounting Officer James Kihara sold 11,421 shares for a transaction value of approximately ~$298,000 on June 26, 2026. The sale represented 46.60% of Kihara's direct holdings and reduced direct ownership to 13,088 sh... Full story

Yahoo Finance • 3 months ago

Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer

-- Experienced global HR leader joins Acadia to advance people strategy and support the next phase of growth SAN DIEGO, July 06, 2026--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Carl Seg... Full story

Yahoo Finance • 3 months ago

Acadia rises as EU backs Rett syndrome therapy

[Diagnosis Rett syndrome and tablets on a wooden table.] designer491 Acadia Pharmaceuticals (ACAD [https://seekingalpha.com/symbol/ACAD]) added ~13% on Friday after an expert panel of the EU drug regulator, the European Medicines Agency,... Full story

Yahoo Finance • 3 months ago

Acadia's DAYBU Recommended For EU Approval In Rett Syndrome; Stock Up In Pre-Market

(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) has moved a step closer to bringing a much-needed therapy to patients with Rett syndrome in Europe. The company announced that the European Medicines Agency's Committee for Medicinal Products... Full story

Yahoo Finance • 5 months ago

ACADIA (ACAD) Upgraded to Buy After Recent Pullback

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ranks among the most profitable biotech stocks to buy now. On March 25, BofA Securities raised ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Buy from Neutral, retaining a $29 price objective. The fi... Full story

Yahoo Finance • 5 months ago

Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting

SAN DIEGO, April 17, 2026--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present multiple original data presentations spanning its portfolio at the 2026 American Academy of Neurology (AAN) Annual... Full story

Yahoo Finance • 6 months ago

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Wall Street’s major market averages ended mixed on Thursday as markets assessed President Donald Trump’s address to the nation and the latest developments in the Middle East conflict. The tech-focused Nasdaq Composite finished +0.1%. At t... Full story

Yahoo Finance • 7 months ago

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing

Palo Alto Investors LP reported a buy of 41,303 shares of PTC Therapeutics(NASDAQ:PTCT) in its February 17, 2026, SEC filing, with an estimated transaction value of $3.00 million based on quarterly average pricing. What Happened Accordin... Full story

Yahoo Finance • 7 months ago

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing

Key Points 209,523-share increase in Dyne Therapeutics; estimated transaction value $3.97 million (based on quarterly average pricing) Quarter-end position in Dyne Therapeutics rose $12.82 million in value, reflecting both trading and sto... Full story

Yahoo Finance • 8 months ago

Acadia Faces EMA Setback On Rett Drug As Regulatory Test Looms

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Acadia Pharmaceuticals (NasdaqGS:ACAD) received a negative trend vote from the European Medicines Agency's Committee f... Full story

Yahoo Finance • 9 months ago

Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

SAN DIEGO, December 18, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive... Full story

Yahoo Finance • 10 months ago

David Einhorn's DME Capital takes stakes in PG&E, exits Teck Resources, among Q3 moves

[business man computer hand holding laptop tablet graph business stock market graph trading analysis investment financial stock exchange graph chart trader stock market analyzing digital technology] panida wijitpanya David Einhorn's DME C... Full story

Yahoo Finance • 12 months ago

Acadia Healthcare Appoints Todd Young as Chief Financial Officer

Young Brings 25 Years of Financial and Healthcare Industry Experience FRANKLIN, Tenn., October 07, 2025--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) ("Acadia" or the "Company") today announced the appointment of Todd Y... Full story

Yahoo Finance • 12 months ago

Stocks Retreat on Higher Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Wednesday closed down -0.28%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.... Full story

Yahoo Finance • 12 months ago

Stocks Pressured as Bond Yields Rise

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.03%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story

Yahoo Finance • 12 months ago

Stocks See Support from Strength in Chip Makers and AI Optimism

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.06%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story